[Federal Register Volume 80, Number 106 (Wednesday, June 3, 2015)]
[Rules and Regulations]
[Pages 31481-31485]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-13509]


=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[EPA-HQ-OPP-2014-0678; FRL-9927-19]


Alkyl (C8-20) Polyglucoside Esters; Exemption From the 
Requirement of a Tolerance

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This regulation establishes an exemption from the requirement 
of a tolerance for residues of D-glucopyranose, oligomeric, 6-
(dihydrogen citrates), C8-20 branched and linear alkyl 
glycosides, sodium salts; D-glucopyranose, oligomeric, 6-(hydrogen 
sulfosuccinates), C8-20 branched and linear alkyl 
glycosides, sodium salts; and D-glucopyranose, oligomeric, lactates, 
C8-20 branched and linear alkyl glycosides when used as an 
inert ingredients (surfactants) in pesticide formulations applied to 
growing crops and raw agricultural commodities after harvest. Lamberti 
USA, Inc. submitted a petition to EPA under the Federal Food, Drug, and 
Cosmetic Act (FFDCA), requesting establishment of an exemption from the 
requirement of a tolerance. This regulation eliminates the need to 
establish a maximum permissible level for residues of D-glucopyranose, 
oligomeric, 6-(dihydrogen citrates), C8-20 branched and 
linear alkyl glycosides, sodium salts: D-glucopyranose, oligomeric, 6-
(hydrogen sulfosuccinates), C8-20 branched and linear alkyl 
glycosides, sodium salts; and D-glucopyranose, oligomeric, lactates, 
C8-20 branched and linear alkyl glycosides.

DATES: This regulation is effective June 3, 2015. Objections and 
requests for hearings must be received on or before August 3, 2015, and 
must be filed in accordance with the instructions provided in 40 CFR 
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).

ADDRESSES: The docket for this action, identified by docket 
identification (ID) number EPA-HQ-OPP-2014-0678, is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory 
Public Docket (OPP Docket)

[[Page 31482]]

in the Environmental Protection Agency Docket Center (EPA/DC), West 
William Jefferson Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW., 
Washington, DC 20460-0001. The Public Reading Room is open from 8:30 
a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The 
telephone number for the Public Reading Room is (202) 566-1744, and the 
telephone number for the OPP Docket is (703) 305-5805. Please review 
the visitor instructions and additional information about the docket 
available at http://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Susan Lewis, Registration Division 
(7505P), Office of Pesticide Programs, Environmental Protection Agency, 
1200 Pennsylvania Ave. NW., Washington, DC 20460-0001; main telephone 
number: (703) 305-7090; email address: [email protected].

SUPPLEMENTARY INFORMATION: 

I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you are an 
agricultural producer, food manufacturer, or pesticide manufacturer. 
The following list of North American Industrial Classification System 
(NAICS) codes is not intended to be exhaustive, but rather provides a 
guide to help readers determine whether this document applies to them. 
Potentially affected entities may include:
     Crop production (NAICS code 111).
     Animal production (NAICS code 112).
     Food manufacturing (NAICS code 311).
     Pesticide manufacturing (NAICS code 32532).

B. How can I get electronic access to other related information?

    You may access a frequently updated electronic version of 40 CFR 
part 180 through the Government Publishing Office's e-CFR site at 
http://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl. To access the OCSPP test guidelines referenced in this 
document electronically, please go to http://www.epa.gov/ocspp and 
select ``Test Methods and Guidelines.''

C. How can I file an objection or hearing request?

    Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an 
objection to any aspect of this regulation and may also request a 
hearing on those objections. You must file your objection or request a 
hearing on this regulation in accordance with the instructions provided 
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify 
docket ID number EPA-HQ-OPP-2014-0678 in the subject line on the first 
page of your submission. All objections and requests for a hearing must 
be in writing, and must be received by the Hearing Clerk on or before 
August 3, 2015. Addresses for mail and hand delivery of objections and 
hearing requests are provided in 40 CFR 178.25(b).
    In addition to filing an objection or hearing request with the 
Hearing Clerk as described in 40 CFR part 178, please submit a copy of 
the filing (excluding any Confidential Business Information (CBI)) for 
inclusion in the public docket. Information not marked confidential 
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without 
prior notice. Submit the non-CBI copy of your objection or hearing 
request, identified by docket ID number EPA-HQ-OPP-2014-0678, by one of 
the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the online instructions for submitting comments. Do not submit 
electronically any information you consider to be CBI or other 
information whose disclosure is restricted by statute.
     Mail: OPP Docket, Environmental Protection Agency Docket 
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC 
20460-0001.
     Hand Delivery: To make special arrangements for hand 
delivery or delivery of boxed information, please follow the 
instructions at http://www.epa.gov/dockets/contacts.html.
    Additional instructions on commenting or visiting the docket, along 
with more information about dockets generally, is available at http://www.epa.gov/dockets.

II. Petition for Exemption

    In the Federal Register of October 15, 2014 (79 FR 61844) (FRL-
9917-24), EPA issued a document pursuant to FFDCA section 408, 21 
U.S.C. 346a, announcing the filing of a pesticide petition (PP IN-
10675) by Lamberti USA, Inc., 161 Washington St., Conshohocken, PA 
19428. The petition requested that 40 CFR 180.910 be amended by 
establishing an exemption from the requirement of a tolerance for 
residues of D-glucopyranose, oligomeric, 6-(dihydrogen citrates), 
C8-20 branched and linear alkyl glycosides, sodium salts 
(CAS Reg. No. 1079993-97-7); D-glucopyranose, oligomeric, 6-(hydrogen 
sulfosuccinates), C8-20 branched and linear alkyl 
glycosides, sodium salts (CAS Reg. No. 1079993-92-2); and D-
glucopyranose, oligomeric, lactates, C8-20 branched and 
linear alkyl glycosides (CAS Reg. No. 1079993-94-4) (hereafter referred 
to in this document as alkyl polyglucoside (C8-20) esters or 
AGEs) when used as inert ingredients (surfactants) in pesticide 
formulations applied to growing crops and raw agricultural commodities. 
That document referenced a summary of the petition prepared by Lamberti 
USA Inc., the petitioner, which is available in the docket, http://www.regulations.gov. One comment was received on the notice of filing. 
EPA's response to this comment is discussed in Unit V.C.

III. Inert Ingredient Definition

    Inert ingredients are all ingredients that are not active 
ingredients as defined in 40 CFR 153.125 and include, but are not 
limited to, the following types of ingredients (except when they have a 
pesticidal efficacy of their own): Solvents such as alcohols and 
hydrocarbons; surfactants such as polyoxyethylene polymers and fatty 
acids; carriers such as clay and diatomaceous earth; thickeners such as 
carrageenan and modified cellulose; wetting, spreading, and dispersing 
agents; propellants in aerosol dispensers; microencapsulating agents; 
and emulsifiers. The term ``inert'' is not intended to imply 
nontoxicity; the ingredient may or may not be chemically active. 
Generally, EPA has exempted inert ingredients from the requirement of a 
tolerance based on the low toxicity of the individual inert 
ingredients.

IV. Aggregate Risk Assessment and Determination of Safety

    Section 408(c)(2)(A)(i) of FFDCA allows EPA to establish an 
exemption from the requirement for a tolerance (the legal limit for a 
pesticide chemical residue in or on a food) only if EPA determines that 
the tolerance is ``safe.'' Section 408(b)(2)(A)(ii) of FFDCA defines 
``safe'' to mean that ``there is a reasonable certainty that no harm 
will result from aggregate exposure to the pesticide chemical residue, 
including all anticipated dietary exposures and all other exposures for 
which there is reliable information.'' This includes exposure through 
drinking water and in residential settings, but does not include 
occupational exposure. Section 408(b)(2)(C) of FFDCA requires EPA to 
give special consideration to exposure of infants and children to the 
pesticide chemical residue in establishing a tolerance and to ``ensure 
that there is a reasonable certainty that no harm will result to 
infants and children from aggregate exposure to the pesticide chemical 
residue. . . .''

[[Page 31483]]

    EPA establishes exemptions from the requirement of a tolerance only 
in those cases where it can be clearly demonstrated that the risks from 
aggregate exposure to pesticide chemical residues under reasonably 
foreseeable circumstances will pose no appreciable risks to human 
health. In order to determine the risks from aggregate exposure to 
pesticide inert ingredients, the Agency considers the toxicity of the 
inert in conjunction with possible exposure to residues of the inert 
ingredient through food, drinking water, and through other exposures 
that occur as a result of pesticide use in residential settings. If EPA 
is able to determine that a finite tolerance is not necessary to ensure 
that there is a reasonable certainty that no harm will result from 
aggregate exposure to the inert ingredient, an exemption from the 
requirement of a tolerance may be established.
    Consistent with FFDCA section 408(c)(2)(A), and the factors 
specified in FFDCA section 408(c)(2)(B), EPA has reviewed the available 
scientific data and other relevant information in support of this 
action. EPA has sufficient data to assess the hazards of and to make a 
determination on aggregate exposure for alkyl polyglucoside 
(C8-20) esters including exposure resulting from the 
exemption established by this action. EPA's assessment of exposures and 
risks associated with alkyl polyglucoside (C8-20) esters 
follows.

A. Toxicological Profile

    EPA has evaluated the available toxicity data and considered their 
validity, completeness, and reliability as well as the relationship of 
the results of the studies to human risk. EPA has also considered 
available information concerning the variability of the sensitivities 
of major identifiable subgroups of consumers, including infants and 
children. Specific information on the studies received and the nature 
of the adverse effects caused by alkyl polyglucoside (C8-20) 
esters as well as the no-observed-adverse-effect-level (NOAEL) and the 
lowest-observed-adverse-effect-level (LOAEL) from the toxicity studies 
are discussed in this unit. Limited toxicity data are available on D-
glucopyranose, oligomeric, 6-(dihydrogen citrates), C8-20 
branched and linear alkyl glycosides, sodium salts); D-glucopyranose, 
oligomeric, 6-(hydrogen sulfosuccinates), C8-20 branched and 
linear alkyl glycosides, sodium salts; and D-glucopyranose, oligomeric, 
lactates, C8-20 branched and linear alkyl glycosides. The 
alkylpolyglucoside (C8-C20) esters are reaction 
products of glucose and fatty acids in which the alcohol moiety is 
attached to the polyglucoside by a [beta]-glucosides linkage. The 
toxicity profile of these substances is based upon data from other, 
related alkyl polyglucoside esters sharing similar physical and 
chemical characteristics as well as expected toxicity as well as AGE 
metabolites lactic acid, citric acid and disodium sulfosuccinate.
    AGEs have low acute toxicity via the oral route (oral 
LD50 > 5,000 milligram/kilogram (mg/kg)). There is no 
available data regarding acute exposure via the dermal, eye or 
inhalation routes.
    In a combined repeated dose toxicity study with the reproduction/
developmental toxicity screening test in rats (OCSPP Guideline 870.3650 
study), there were no observed adverse effects for parental systemic or 
reproductive/developmental toxicity at 1,000 mg/kg/day.
    A 2-year chronic oral study in rats treated with citric acid was 
available for review. Rats were administered 5 percent or 3 percent 
citric acid (approx. 2,000 or 1,200 mg/kg/day) in the diet. There were 
no adverse effects observed at 2,000 mg/kg/day. Chronic studies were 
also available for the rabbit and dog. There were no adverse effects 
observed in either study at doses up to 1,500 and 1,400 mg/kg/day, 
respectively.
    Neurotoxicity studies with AGEs were not available for review. 
However, neurotoxicity was not observed in the combined repeated dose 
toxicity study with the reproduction/developmental toxicity screening 
test at concentrations as high as 1,000 mg/kg/day (limit dose).
    Mutagenicity studies on several surrogate chemicals did not 
indicate positive response for mutagenic effects. The Agency further 
evaluated the carcinogenic potential of alkyl polyglucoside 
(C8-20) esters by conducting a knowledge base qualitative 
structure activity relationship (SAR) database search, DEREK Nexus 
Version 2.0, to determine if there were structural alerts. No 
structural alerts were identified including carcinogenicity.
    Alkylpolyglycosides are rapidly hydrolyzed in intestine and liver. 
The cleavage products, sugars and long-chain alcohols, enter the 
pathways of lipid and carbohydrate metabolism.
    Specific information on the studies received and the nature of the 
adverse effects caused by, can be found at http://www.regulations.gov 
in the document ``PC Codes 911028, 911029, 911030: Alkyl 
(C8-20) polyglucoside Esters (AGEs); Human Health Risk 
Assessment and Ecological Effects Assessment to Support Proposed 
Exemption from the Requirement of a Tolerance When Used as Inert 
Ingredients in Pesticide Formulations.'' at (6) in docket ID number 
EPA-HQ-OPP-2014-0678.

B. Toxicological Points of Departure/Levels of Concern

    Alkylglycosides are rapidly hydrolyzed in intestine and liver. The 
cleavage products, sugars, and long-chain alcohols enter the pathways 
of lipid and carbohydrate metabolism. Based on the low acute toxicity 
of AGEs, the body's ability to rapidly metabolize these substances, the 
expected metabolites being fatty acids and carbohydrates (which are 
normal constituents of the body), and the lack of observed adverse 
effects for repeat dose studies at the limit dose (1,000 mg/kg/day), no 
endpoint of concern was identified.

C. Exposure Assessment

    1. Dietary exposure from food and feed uses. In evaluating dietary 
exposure to alkyl polyglucoside (C8-20) esters, EPA 
considered exposure under the proposed exemption from the requirement 
of a tolerance. EPA assessed dietary exposures from alkyl polyglucoside 
(C8-20) esters in food as follows:
    Dietary exposure to AGEs can occur from eating food treated with 
alkyl polyglucoside (C8-20) esters. However, a quantitative 
assessment was not conducted since an endpoint of concern for risk 
assessment was not identified.
    2. Dietary exposure from drinking water. Dietary exposure from 
drinking water to alkyl polyglucoside (C8-20) esters can 
occur by drinking water that has been contaminated by run-off from a 
pesticide treated area. Since an endpoint for risk assessment was not 
identified, a quantitative dietary exposure assessment from drinking 
water for alkyl polyglucoside (C8-20) esters was not 
conducted.
    3. From non-dietary exposure. The term ``residential exposure'' is 
used in this document to refer to non-occupational, non-dietary 
exposure (e.g., textiles (clothing and diapers), carpets, swimming 
pools, and hard surface disinfection on walls, floors, tables).
    Alkyl polyglucoside (C8-20) esters have reported uses in 
personal care products, such as antiperspirants, shampoos, 
conditioners, and moisturizers. Residential exposure to alkyl 
polyglucoside (C8-20) esters via the oral, dermal, and 
inhalation route of exposure is also possible as a result of their use 
as inert ingredients in registered pesticide products that

[[Page 31484]]

include residential uses. However, since there is toxicological 
endpoint identified, it is not necessary to conduct assessments of 
residential (non-occupational) exposures and risks.
    4. Cumulative effects from substances with a common mechanism of 
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when 
considering whether to establish, modify, or revoke a tolerance, the 
Agency consider ``available information'' concerning the cumulative 
effects of a particular pesticide's residues and ``other substances 
that have a common mechanism of toxicity.''
    EPA has not found Alkyl polyglucoside (C8-20) esters to 
share a common mechanism of toxicity with any other substances, and 
Alkyl polyglucoside (C8-20) esters do not appear to produce 
a toxic metabolite produced by other substances. For the purposes of 
this tolerance action, therefore, EPA has assumed that Alkyl 
polyglucoside (C8-20) esters do not have a common mechanism 
of toxicity with other substances. For information regarding EPA's 
efforts to determine which chemicals have a common mechanism of 
toxicity and to evaluate the cumulative effects of such chemicals, see 
EPA's Web site at http://www.epa.gov/pesticides/cumulative.

D. Safety Factor for Infants and Children

    Section 408(b)(2)(C) of FFDCA provides that EPA shall apply an 
additional tenfold (10X) margin of safety for infants and children in 
the case of threshold effects to account for prenatal and postnatal 
toxicity and the completeness of the database on toxicity and exposure 
unless EPA determines based on reliable data that a different margin of 
safety will be safe for infant and children. This additional margin of 
safety is commonly referred to as the FQPA Safety Factor (SF). In 
applying this provision, EPA either retains the default value of 10X, 
or uses a different additional safety factor when reliable data 
available to EPA support the choice of a different factor. The database 
is considered adequate for FQPA assessment. Fetal susceptibility was 
not observed in the combined repeated dose toxicity study with the 
reproduction/developmental toxicity screening test in the rat. There 
were no toxic effects observed in either study at the highest doses 
tested, 1,000 mg/kg/day. Signs of neurotoxicity were not observed in 
any of the submitted studies. No treatment related effects in a 
functional observational battery--(FOB) and on motor activity 
parameters were observed at doses up to 1,000 mg/kg/day; EPA has 
concluded that a developmental neurotoxicity study is not required. 
Signs of potential immunotoxicity were not observed in any of the 
submitted studies. Based on its assessment of available data for AGEs 
as discussed in Unit IV.A., EPA has concluded that there are no 
toxicological endpoints of concern for the U.S. population, including 
infants and children, and has conducted a qualitative assessment. As 
part of its qualitative assessment, the Agency did not use safety 
factors for assessing risk, and no additional safety factor is needed 
for assessing risk to infants and children.

E. Aggregate Risks and Determination of Safety

    Taking into consideration all available information on D-
qlucopyranose, oligomeric, 6-(dihydrogen citrates), C8-20 
branched and linear alkyl glycosides, sodium salts; D-glucopyranose, 
oligomeric, 6-(hydrogen sulfosuccinates), C8-20 branched and 
linear alkyl glycosides, sodium salts; and D-glucopyranose, oligomeric, 
lactates, C8-20 branched and linear alkyl glycosides, EPA 
has determined that there is a reasonable certainty that no harm to any 
population subgroup will result from aggregate exposure to D-
glucopyranose, oligomeric, 6-(dihydrogen citrated), C8-20 
branched and linear alkyl glycosides, sodium salts; D-glucopyranose, 
oligomeric, 6-(hydrogen sulfosuccinates),
    C8-20 branched and linear alkyl glycosides, sodium 
salts; and D-glucopyranose, oligomeric, lactates, C8-20 
branched and linear alkyl glycosides under reasonable foreseeable 
circumstances. Therefore, the establishment of an exemption from 
tolerance under 40 CFR 180.910 for residues of D-glucopyranose, 
oligomeric, 6-(dihydrogen citrates), C8-20 branched and 
linear alkyl glycosides, sodium salts; D-glucopyranose, oligomeric, 6-
(hydrogen sulfosuccinated), C8-20 branched and linear alkyl 
glycosides, sodium salts; and D-glucopyranose, oligomeric, lactates, 
C8-20 branched and linear alkyl glycosides when used as 
inert ingredients in pesticide formulations applied to growing crops 
and raw agricultural commodities after harvest, is safe under FFDCA 
section 408.

V. Other Considerations

A. Analytical Enforcement Methodology

    An analytical method is not required for enforcement purposes since 
the Agency is establishing an exemption from the requirement of a 
tolerance without any numerical limitation.

B. Response to Comments

    One comment was received in response to the notice of filing. The 
comment received was from a private citizen who opposed any pesticide 
product that leaves a residue above 0.00. The Agency understands the 
commenter's concerns and recognizes that some individuals believe that 
no residue of pesticides should be allowed. However, under the existing 
legal framework provided by FFDCA section 408, EPA is authorized to 
establish pesticide tolerances or exemptions where persons seeking such 
tolerances or exemptions have demonstrated that the pesticide meets the 
safety standard imposed by the statute.

VI. Conclusions

    Therefore, an exemption from the requirement of a tolerance is 
established under 40 CFR 180.910 for D-glucopyranose, oligomeric, 6-
(dihydrogen citrates), C8-20 branched and linear alkyl 
glycosides, sodium salts (CAS Reg. No. 1079993-97-7); D-glucopyranose, 
oligomeric, 6-(hydrogen sulfosuccinates), C8-20 branched and 
linear alkyl glycosides, sodium salts (CAS Reg. No. 1079993-92-2); and 
D-glucopyranose, oligomeric, lactates, C8-20 branched and 
linear alkyl glycosides (CAS Reg. No. 1079993-94-4) esters when used as 
inert ingredients (surfactants) in pesticide formulations applied to 
growing crops and raw agricultural commodities after harvest.

VII. Statutory and Executive Order Reviews

    This action establishes exemptions from the requirement of a 
tolerance under FFDCA section 408(d) in response to a petition 
submitted to the Agency. The Office of Management and Budget (OMB) has 
exempted these types of actions from review under Executive Order 
12866, entitled ``Regulatory Planning and Review'' (58 FR 51735, 
October 4, 1993). Because this action has been exempted from review 
under Executive Order 12866, this action is not subject to Executive 
Order 13211, entitled ``Actions Concerning Regulations That 
Significantly Affect Energy Supply, Distribution, or Use'' (66 FR 
28355, May 22, 2001) or Executive Order 13045, entitled ``Protection of 
Children from Environmental Health Risks and Safety Risks'' (62 FR 
19885, April 23, 1997). This action does not contain any information 
collections subject to OMB approval under the Paperwork Reduction Act 
(PRA) (44 U.S.C. 3501 et seq.), nor does it require

[[Page 31485]]

any special considerations under Executive Order 12898, entitled 
``Federal Actions to Address Environmental Justice in Minority 
Populations and Low-Income Populations'' (59 FR 7629, February 16, 
1994).
    Since tolerances and exemptions that are established on the basis 
of a petition under FFDCA section 408(d), such as the exemptions in 
this final rule, do not require the issuance of a proposed rule, the 
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et 
seq.), do not apply.
    This action directly regulates growers, food processors, food 
handlers, and food retailers, not States or tribes, nor does this 
action alter the relationships or distribution of power and 
responsibilities established by Congress in the preemption provisions 
of FFDCA section 408(n)(4). As such, the Agency has determined that 
this action will not have a substantial direct effect on States or 
tribal governments, on the relationship between the national government 
and the States or tribal governments, or on the distribution of power 
and responsibilities among the various levels of government or between 
the Federal Government and Indian Tribes. Thus, the Agency has 
determined that Executive Order 13132, entitled ``Federalism'' (64 FR 
43255, August 10, 1999) and Executive Order 13175, entitled 
``Consultation and Coordination with Indian Tribal Governments'' (65 FR 
67249, November 9, 2000) do not apply to this action. In addition, this 
action does not impose any enforceable duty or contain any unfunded 
mandate as described under Title II of the Unfunded Mandates Reform Act 
(UMRA) (2 U.S.C. 1501 et seq.).
    This action does not involve any technical standards that would 
require Agency consideration of voluntary consensus standards pursuant 
to section 12(d) of the National Technology Transfer and Advancement 
Act (NTTAA) (15 U.S.C. 272 note).

VIII. Congressional Review Act

    Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.), 
EPA will submit a report containing this rule and other required 
information to the U.S. Senate, the U.S. House of Representatives, and 
the Comptroller General of the United States prior to publication of 
the rule in the Federal Register. This action is not a ``major rule'' 
as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 180

    Environmental protection, Administrative practice and procedure, 
Agricultural commodities, Pesticides and pests, Reporting and 
recordkeeping requirements.

    Dated: May 18, 2015.
Daniel J. Rosenblatt,
Acting Director, Registration Division, Office of Pesticide Programs.

    Therefore, 40 CFR chapter I is amended as follows:

PART 180--[AMENDED]

0
1. The authority citation for part 180 continues to read as follows:

    Authority:  21 U.S.C. 321(q), 346a and 371.


0
2. Amend Sec.  180.910 by adding alphabetically the following inert 
ingredients to the table to read as follows:


Sec.  180.910  Inert ingredients used pre- and post-harvest; exemptions 
from the requirement of a tolerance.

* * * * *

------------------------------------------------------------------------
        Inert ingredients                Limits               Uses
------------------------------------------------------------------------
 
                              * * * * * * *
D-glucopyranose, oligomeric, 6-    ..................  Surfactant.
 (dihydrogen citrates), C8	20
 branched and linear alkyl
 glycosides, sodium salts (CAS
 Reg. No. 1079993-97-7).
D-glucopyranose, oligomeric, 6-    ..................  Surfactant.
 (hydrogen sulfosuccinates),
 C8	20 branched and linear alkyl
 glycosides, sodium salts (CAS
 Reg. No. 1079993-92-2).
D-glucopyranose, oligomeric,       ..................  Surfactant.
 lactates, C8	20 branched and
 linear alkyl glycosides (CAS
 Reg. No. 1079993-94-4).
 
                              * * * * * * *
------------------------------------------------------------------------

[FR Doc. 2015-13509 Filed 6-2-15; 8:45 am]
 BILLING CODE 6560-50-P